Reddit Dropped, Defence and Pharma Lifted
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
Evercore ISI analyst Mark Mahaney downgraded RDDT from Buy to Hold on Monday. His target price fell from $265 to $120. That is a 55% cut in one move. Reddit carries short interest of 15% of free float, so bearish analyst pressure lands on an already crowded short.
Guggenheim swept through the healthcare sector with upgrades. Analyst Vamil Divan raised his ABBV target to $322 from $288, keeping a Buy rating. The pharma giant sits at a $521 billion market cap. Colleague Yatin Suneja lifted his REGN target to $1,100 from $1,030, also on a Buy.
The defence sector drew attention too. Wells Fargo analyst David Strauss raised his LMT target by $100 to $700, maintaining a Hold. The MSCI Index Rebalance Radar flags that CTVA (Corteva) faces a 77% deletion probability from MSCI World, with $555 million of forced selling possible on 30 November. Lockheed's index position remains stable for now.
CLX (Clorox) received a rare upgrade from Evercore ISI, moving from Sell to Hold. The consumer staples stock has had a difficult year.
Wells Fargo also raised targets on RSG (Republic Services) to $270 from $234 and on chemicals name LYB to $76 from $70, both on Buy ratings.
Stocks in this article
How this article was generated
- Generated
- 2 Nov 2026, 20:22
- Prompt version
- v1.0
- Data sources
- Analyst consensusAlt DataIndex Rebalance
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.